Efficacy and safety of IL-17 inhibitors for the treatment of ankylosing spondylitis: a systematic review and meta-analysis

• Published in: Arthritis research & therapy Vol. 22; no. 1; pp. 111 - 11
• Main Authors: Yin, Yufeng, Wang, Mingjun, Liu, Mengru, Zhou, Erye, Ren, Tian, Chang, Xin, He, Michun, Zeng, Keqin, Guo, Yufan, Wu, Jian
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 12.05.2020; BioMed Central; BMC
• Subjects: Analysis; Ankylosing spondylitis; Arthritis; Clinical trials; Cytokines; Drug therapy; Efficacy; Interleukin inhibitors; Interleukins; Meta-analysis; Monoclonal antibodies; Patient safety; Psoriasis; Safety; Suicides & suicide attempts; Systematic review; Efficacy; Interleukin inhibitors; Safety; Ankylosing spondylitis; Meta-analysis

To systematically assess the efficacy and safety of IL-17 inhibitors in patients with active ankylosing spondylitis. A systematic review of the literature was performed for randomized controlled trials (RCTs) concerning IL-17 inhibitors in patients with ankylosing spondylitis. Meta-analyses were use...